Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Laboratorios Farmaceúticos Rovi Total Assets (Quarterly) : 1.067B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.067B |
| December 31, 2025 | 1.122B |
| September 30, 2025 | 1.083B |
| June 30, 2025 | 1.021B |
| March 31, 2025 | 879.24M |
| December 31, 2024 | 861.56M |
| September 30, 2024 | 979.72M |
| June 30, 2024 | 918.84M |
| March 31, 2024 | 840.96M |
| December 31, 2023 | 883.59M |
| September 30, 2023 | 879.53M |
| June 30, 2023 | 981.72M |
| March 31, 2023 | 961.72M |
| December 31, 2022 | 937.80M |
| September 30, 2022 | 756.75M |
| June 30, 2022 | 827.54M |
| March 31, 2022 | 828.77M |
| December 31, 2021 | 833.20M |
| September 30, 2021 | 793.96M |
| June 30, 2021 | 764.01M |
| March 31, 2021 | 695.05M |
| December 31, 2020 | 702.85M |
| September 30, 2020 | 658.69M |
| June 30, 2020 | 610.80M |
| March 31, 2020 | 577.88M |
| Date | Value |
|---|---|
| December 31, 2019 | 573.83M |
| September 30, 2019 | 492.96M |
| June 30, 2019 | 511.46M |
| March 31, 2019 | 480.20M |
| December 31, 2018 | 460.35M |
| September 30, 2018 | 367.22M |
| June 30, 2018 | 364.56M |
| March 31, 2018 | 377.97M |
| December 31, 2017 | 358.30M |
| September 30, 2017 | 342.40M |
| June 30, 2017 | 345.59M |
| March 31, 2017 | 322.94M |
| December 31, 2016 | 303.61M |
| September 30, 2016 | 304.91M |
| June 30, 2016 | 309.51M |
| March 31, 2016 | 302.44M |
| December 31, 2015 | 286.62M |
| September 30, 2015 | 292.56M |
| June 30, 2015 | 294.81M |
| March 31, 2015 | 281.26M |
| December 31, 2014 | 316.21M |
| September 30, 2014 | 309.91M |
| June 30, 2014 | 339.06M |
| March 31, 2014 | 326.08M |
| December 31, 2013 | 325.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Almirall SA | 2.685B |
| AstraZeneca PLC | 114.02B |
| ANI Pharmaceuticals, Inc. | 1.422B |
| Corcept Therapeutics, Inc. | 814.88M |
| Assertio Holdings, Inc. | 211.30M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 276.05M |
| Shareholders Equity (Quarterly) | 776.47M |
| Debt to Equity Ratio | 0.1698 |
| Current Ratio | 3.655 |
| Net Debt Paydown Yield | -0.08% |